Zhang Ge
Associate Professor
Department of Orthopaedics and Traumatology
Institute of Integrated Bioinformedicine and Translational Science
Hong Kong
Biography
Name: Zhang Ge Academic qualifications: 1990.9-1995.7 B. Med Shanghai University of Chinese Medicine, Shanghai, China 1997.9-2000.7 M. Med. Institute of Orthopaedics & Traumatology, Shanghai University of Chinese Medicine, China 2000.9-2003.7 M.D. Institute of Orthopaedics & Traumatology, Shanghai University of Chinese Medicine & Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong Previous academic positions held: 1995.8-2000.11 Resident Institute of Orthopaedics & Traumatology, Shu Guang Hospital, Shanghai University of Chinese Medicine 2000.12-2004.2 Physician-in-Charge Institute of Orthopaedics & Traumatology, Shu Guang Hospital, Shanghai University of Chinese Medicine 2004.3-2007.6 Postdoctoral Research Fellow Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong 2007.7-2012.8 Research Assistant Professor Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong Present academic position: 2012.9- Associate Professor Ge Zhang’s Lab (www.gezhanglab.com), Institute for Advancing Translational Medicine in Bone & Joint Diseases, Hong Kong Baptist University & Teaching Division, School of Chinese Medicine, Hong Kong Baptist University Previous relevant research work: Technical expertise Bone bio-imaging, Bone histomorphometry, Bone biology, Bone biomechanics Research area Molecular understandings and RNAi-based & phytotherapy-based translational research in osteoporosis, osteonecrosis, osteoarthritis, rheumatoid arthritis and facture repair
Research Interest
Molecular understandings and RNAi-based & phytotherapy-based translational research in osteoporosis, osteonecrosis, osteoarthritis, rheumatoid arthritis and facture repair
Publications
-
Zhao N, Li J, Li L, Niu XY, Jiang M, He XJ, Bian ZX, Zhang G, Lu AP. Molecular network-based analysis of Guizhi-Shaoyao-Zhimu decoction, a TCM herbal formula, for treatment of diabetic peripheral neuropathy. Acta Pharmacologica Sinica. 2015 Jun;36(6):716.
-
Liu H, Yin J, Wang H, Jiang G, Deng M, Zhang G, Bu X, Cai S, Du J, He Z. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells. Cellular signalling. 2015 Mar 31;27(3):510-8.
